v3.26.1
Balance Sheet Details (Tables)
 6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Available-for-Sale Investments
The following is a summary of the Company’s available-for-sale investments (in thousands):
June 30, 2026
Amortized CostGross Unrealized
Gains		Gross Unrealized
Losses		Estimated Fair
Value
U.S. treasury bills$4,474 $— $(3)$4,471 
U.S. commercial paper7,988 — (1)7,987 
Foreign commercial paper5,485 — (1)5,484 
Total$17,947 $— $(5)$17,942 
December 31, 2025
Amortized CostGross Unrealized
Gains		Gross Unrealized
Losses		Estimated Fair
Value
U.S. treasury bills$3,995 $2 $— $3,997 
U.S. government agency obligations3,002 — (1)3,001 
U.S. corporate debt securities1,000 1 — 1,001 
U.S. commercial paper10,974 — (1)10,973 
Foreign commercial paper8,460 — (2)8,458 
Total$27,431 $3 $(4)$27,430 
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consist of the following (in thousands):
June 30, 2026December 31, 2025
Prepaid clinical and manufacturing expenses$2,848 $5,825 
Prepaid insurance496 329 
Prepaid taxes302 243 
Interest receivables22 148 
Other prepaid expenses and current assets533 29 
Total prepaid expenses and other current assets$4,201 $6,574 
Schedule of Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
June 30, 2026December 31, 2025
Accrued clinical, manufacturing and professional expense$11,795 $8,086 
Accrued compensation and benefits1,873 2,914 
Other accrued expenses224 160 
Total accrued liabilities$13,892 $11,160